SARTF (Sartorius AG) Quick Ratio: 0.52 (As of Mar. 2026) — 32% Below Median


SARTF Sartorius AG SARTF
85 GF Score
Price $192.43
GF Value $226.12
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Sartorius AG Quick Ratio?

Sartorius AG SARTF -1.83% 85 Quick Ratio is 0.52 as of Mar. 2026, which is 32% below its 10-year median of 0.77. GuruFocus rates SARTF with a GF Score™ of 85/100 and a GF Value™ of $226.12 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Sartorius AG ranks worse than 91.33% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Sartorius AG's quick ratio for the quarter that ended in Mar. 2026 was 0.52.

Sartorius AG has a quick ratio of 0.52. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Sartorius AG's Quick Ratio or its related term are showing as below:

SARTF' s Quick Ratio Range Over the Past 10 Years
Min: 0.43   Med: 0.77   Max: 1.3
Current: 0.52

During the past 13 years, Sartorius AG's highest Quick Ratio was 1.30. The lowest was 0.43. And the median was 0.77.

SARTF's Quick Ratio is ranked worse than
91.33% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.865 vs SARTF: 0.52

Sartorius AG  (OTCPK:SARTF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Sartorius AG Quick Ratio Related Terms


Sartorius AG Quick Ratio Historical Data

* Premium members only.

The historical data trend for Sartorius AG's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG Quick Ratio Chart

Sartorius AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.47 0.69 0.92 0.50

Sartorius AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 0.88 0.49 0.50 0.52

SARTF vs ISRG, BDX, MDLN: Quick Ratio Comparison

For the Medical Instruments & Supplies subindustry, Sartorius AG's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG Quick Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Quick Ratio falls into.


SARTF
85GF Score
Sartorius AG SARTF
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius AG Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Sartorius AG's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2068.15-927.635)/2303.747
=0.50

Sartorius AG's Quick Ratio for the quarter that ended in Mar. 2026 is calculated as

Quick Ratio (Q: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2223.584-956.185)/2443.006
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.52 mean?
Sartorius AG (SARTF) has a Quick Ratio of 0.52 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sartorius AG and its competitors. This is 32% below median its historical median of 0.77. Over the past decade, Sartorius AG's Quick Ratio has ranged from 0.43 to 1.30. According to the industry distribution chart, Sartorius AG ranks #780 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 91.3%.
Is Sartorius AG's Quick Ratio too high?
Sartorius AG's current Quick Ratio of 0.52 is 32% below median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 1.30. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Sartorius AG's value of 0.52 is 72.1% below this industry median. Based on the distribution chart, Sartorius AG ranks #780 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sartorius AG has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's Quick Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sartorius AG ranks #780 out of 854 companies for Quick Ratio. This places Sartorius AG in the lower half of its industry. The industry median Quick Ratio is 1.87. Sartorius AG's value of 0.52 is 72.1% below this benchmark. Historically, Sartorius AG's own Quick Ratio has ranged from 0.43 to 1.30 over the past decade. While the company's 10-year median is 0.77 vs. the industry median of 1.87, Sartorius AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sartorius AG's current Quick Ratio of 0.52 is 72.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sartorius AG and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sartorius AG's current Quick Ratio is 0.52, which is 32% below median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Based on GuruFocus' analysis, Sartorius AG (SARTF) is currently considered Modestly Undervalued. The stock's GF Value™ is $226.12, compared to a current price of $192.43 — trading 14.9% below its estimated fair value. The current Quick Ratio is 0.52, which is 32% below median its 10-year median of 0.77 and 72.1% below the Medical Devices & Instruments industry median of 1.87. Sartorius AG's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Sartorius AG (SARTF), the current Quick Ratio is 0.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius AG (SARTF) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued. The current stock price of $192.43 is trading 14.9% below its estimated GF Value™ of $226.12. GuruFocus considers Sartorius AG to be Modestly Undervalued.

Key valuation signals for SARTF:

  • Quick Ratio: 0.52 (32% below median its 10-year median of 0.77)
  • GF Value™: $226.12 vs. price of $192.43 (14.9% below fair value)
  • GF Score™: 85/100 with 6 warning signs
  • Industry Position: 72.1% below the Medical Devices & Instruments median (#780 of 854)

No single metric tells the full story. See the SARTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius AG Business Description

Address Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
85GF Score

Get the complete analysis for SARTF

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$192.43
Price
$226.12
GF Value